COMPANY OVERVIEW

Braeburn is dedicated to delivering solutions for people living with the serious, often fatal consequences of opioid use disorder.

---

LOCATION

Plymouth Meeting, PA, USA

---

THERAPEUTIC AREAS

Pain

---

WEBSITE

https://braeburnrx.com/

---

CAREER WEBSITE

https://braeburnrx.com/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Jun 12, 2023

Braeburn Whisky, Trusted Whisky Cask Investment Experts, Launch in United States

May 23, 2023

Braeburn's BRIXADI™ (buprenorphine) Extended-Release Subcutaneous Injection (CIII) Receives FDA Approval for Moderate to Severe Opioid Use Disorder

Dec 8, 2022

FDA Accepts Braeburn's New Drug Application Resubmission for BRIXADI™ (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder

Oct 14, 2022

NLRB to Prosecute Braeburn Alloy Steel over Unfair Labor Practices

Jun 26, 2021

FDA Accepts Braeburn's New Drug Application Resubmission for BRIXADI™ (buprenorphine) Extended-Release Subcutaneous Injection for Moderate to Severe Opioid Use Disorder

For More Press Releases

---